This residual IRE1α activity provided a rationale to the fact that glioblastomas expressing IRE1α-K599A mutant exhibited moderate infiltrative features: diffuse lesions had lower penetrance (∼60%), grew less compact than control tumors and no co-option was observed. The gene discussed is ERN1; the disease is glioblastoma.